Effects of dental treatment and systemic disease on oral health-related quality of life in Korean pediatric patients

Abstract

Background The findings that not only dental caries but also systemic disease can exert a negative effect on oral health-related quality of life (OHRQoL), and that dental treatment can improve OHRQoL have been confirmed in multiple studies. The purpose of this study is to investigate the impact of dental treatment on OHRQoL of Korean pediatric patients and the differences in OHRQoL between patients with and without systemic disease.

Methods All the primary caregivers of pediatric patients who underwent dental treatments under either general anesthesia or intravenous deep sedation at Seoul National University Dental Hospital completed abbreviated versions of the Child Oral Health Impact Profile (COHIP-14) and Family Impact Scale (FIS-12) surveys on OHRQOL pre- and post-treatment (average: 2.4 ± 1.7months after dental treatment). This is a case control study with patients divided into two groups according to the presence or absence of systemic disease.

Results Data from 93 pediatric patients (46 male and 47 female, average patient age: 5.0 ± 3.4years) were analyzed to compare OHRQoL before and after treatment with the Wilcoxon signed-rank test and to calculate the effect size using Cohens d. All of the patients exhibited an improvement in OHRQoL (COHIP-14: p< 0.001, effect size = 1.0; FIS-12: p< 0.001, effect size = 0.7). Patients with systemic diseases demonstrated lower OHRQoL in both pre- and post-treatment surveys than patients without systemic diseases (Wilcoxon Rank-sum test, both COHIP-14 and FIS-12: p< 0.05). The COHIP-14 appears to have a greater impact on the FIS-12 in patients with systemic disease than those without (explanatory power of 65.3 and 44.6%, respectively).

Conclusions Based on the primary caregivers perceptions, dental treatment can improve the OHRQoL in Korean pediatric patients. Systemic disease results in a reduced OHRQoL, and the awareness of patients oral health appeared to have a greater impact on OHRQoL for family members of patients with a systemic disease.

Trial registration KCT0002473(Clinical Research Information Service, Republic of Korea) and 22 Sep 2017, retrospectively registered.